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Abstract. Mi!!il770la,' concentrations of dopamine (DA), noll~'pi-
nephi?fne (NE), ancl 3, 4-dih.yc!lv~yphc'nyJacc'tic ctcic! (DOJ)A C) 
vi'c'f~i' cytotoxic to hulncm prOlnyelocytic leuk'e,77ic HL-60 cells. 
Howc'vc", the･i,' /7?etabol ites (3, 4-d ih.yc[/ vxymand elic a cicl 
(D()MA), 3-lnc'thoxyty,rllninc' (MT), nol'n7c'tanc'ph,i,7e (1Vl~fN)) 
ancl six ,syntl7etic deljvativc's (w/7ich havc' two OCH3 g!roups 
'~!'placing t}vo OH .()Troups on catecl70l bcickbo,?e) clisplayecl J??uch 
lowe/' c.ytotoxic activty. Th.rec' active colnpou.nds, but not othel' 
less potenj compounc!s, p]vc!uced ,~lrdica/s unc!e,' aJkali,?e 
col"Iclitions. All actil;c' col77pounds si.~Jmficant!y enhanced the 
dc'ccty oj asco/hlc acld endogenous/y plesc'i?t l/? rat brain 
/70n70.~'c'nale, where'as all ,sy. nt/?etic delivati};es vvere inactiT!e. 
Ascol'bic ctcicl ill.ducc'c! apoptotic cc'!/ cic'ath ill HL-60 cel!s a/7.d 
the apoptosis induction was si.~'nificantl_y recluced by 
simultaneous additioll of (DA). The cy'totoxic activity of (DA) 
vvas a/so neut/~7lized by ascol'bic acid. These c[ata suggc'st tl?e 
possible inte!~:rcti0,7 betwc'c'n (DA) alrd asc0,1)ic acid. 
Dop'(Imines such as DOPA (3-hyclroxytyrosine). , dopamine 
[DA, l], norepinephrine (noradren(alin, NE [2]) and 
epinephrine ('aclren'alin) have shown '(mtitumor activity against 
Abbre,,'iations: Dop'amine hydrochloride [DA, I]; norepine-
phrine jNE, 2]; 3,4-ciihydroxypheny]acetic acicl [DOPAC, 3]; 3,4-
dihydroxymandelic acid [DOMA, 4]; 3-methoxytyramine [MT, 
-~j; normet~inephrine [NMN, 6]; N-[･_-(3,4-dimethox.vphenyl)-
ethyl]-N-methanesulfonylal'anine (KD l, [7]); N-[2-(3_ ,4-dimetho-
xyphenyl)ethyl]-N-trifl~ uoromethanesulfonyla]anine (KD2 [8]) 
N-(2-phenylethyl)-N-trifluoromethanesulfonylglycine (KD_3, 
[9]); N-[2-(3,4-dirnethoxyphenyl)ethyl]-N-trifluoromethanesulfo-
nyiglycine (KD4, [lO]); N-[2-(3,4-ciimethoxyphenyi)ethyl]-N-
trifluoromethanesulfonylvaline (KD5, [11]); N-[2-(3,4-dimetho-
xyphenyl)ethyl]-2-phenyl-N-trifiuoromethanesulfonyl (KD6, 
[12]); 2-(3,4-dimethoxyphenyl)ethylamine oxalate (KD7, [13]) 
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murine s rcoma 180 tumor (1). Sarcoma 180 tumor cells 
exposed to d fferent c(3 ncentrations of dop'amine [l] showed 
significantly reduced ~H thymidine incorporation into the 
tumor cells (2). A neurotoxic 6-hydroxydopamine retardeci 
the grow h of Cl300 neurobl･astoma 'and the AIO breast 
'adenocarcinoma (3). NE [2] increased the blood supply to 'a 
rat f br sar oma and, when combined with methotrexate, 
aused a reduction in umor size (4). DA [1] stimulated 
aclenylate cyclase activity in malignant neurob]astoma cel]s 
(5). DA [1] possesed antitumor activity ag'ainst B16 
melanoma, C1300 neuroblastoma, and L1^210 and P388 
lymphocy ic leukemias (6-8). Complex formation with 
ascorbic acid enhanced the cytotoxic ef'fcct of 6-
hydroxydopamine, suggesting the oxygen radic'al generation 
by 6-hydroxydopamine (9~ -11). Third, DA [1] is one of a 
neurotransmit er and i s lcvel in the brain significantly 
declined in nerve diseases, such as Parkinsonism. Tempol (4-
hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl) acted as a free 
radical sc'avenger in murl neYroblastoma cells by reacting 
directl), w th both the 6-hydroxydop',Imine radical and, in the 
presence of iron, its oxidation product, the hydroxy radic',il 
(12). However, the mechanism by which DA induces 
cytotoxicity has not yet been elucidated. We have recent]y 
found that ascorbate- (1^3), gallate- (14) and 
benzo[a]phenothiazine-rel',tted corripounds (15,1.6), which 
produced r'adicals, induced apoptosis or differentiation, 
whereas those, which did not produce radicals, were rather 
inactive. This suggests the importance of radical production 
for expression of bio]ogical acti¥'ity. In extension of these 
studies, ¥ve investig',rtecl here the relationship between radical 
intensi y and cytotoxic activity of authentic and synthetic DA 
analogs, using ESR spectroscopy. 
Materials nd Methods 
Chemica!s. The following chemicals ~verc oht',iincd from the indicated 
comp2inies. DA hydrochloride [1], 3-methoxytyl imme [MT. 5] 
normctanephrine [NMN, 6J (Sigm~i, U.SA.); norepineph~'ine [NE 2], 
3,4-dihydroxv.phenyi'acetic acid [DOPAC, 3], 3,4-dihyciroxym',tndelic 2lcid 
[DOMA, 4] (Aldrich); RPlvill640 mediun~ (GIBCo, Gra~~d lsl~~nd, 
N.Y.); ascorbic 'acid (Tok),o Kasei. Tokyo); sodium 5,6-hen7..ylicicne-1-
~~scorb te (SBA) (strpplied by Dr. M. Kochi); i'etal bovine sen]ITi (FBS) 
(JRH Biosc). 
O250700_~lc)8 $2.00+ .40 l O()c) 
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Figure 1. The st'l Lire of3, 4-dihydrorydopalnines fl-4J, 3-lnethoxy-4-hydroxydopamines f5,6J, and synthetic DA ana!ogs f7-13J. 
?
B (+ 50'/* DMSO) 
pH 9.5 pH 12.5 DA [1] 1~__~~¥~---~{¥ L~v~---~{L ?? ?
f~___ i¥ ~- -J4',rli , . ~ NE t2] ~ -1~ ??;! {,,i DOPAC 13] ~'~~L~J,:i.;!}--- ~ ~Jt:jil.r~ ~i ??
DOMA [4] iL_J~ i,~: !¥ f~ , ~~ ~;~~~! ~~f~~i MT [5] !~ ~- ~ ??~ Y .. ~ ~1i' NMN 16] ~ i~--~fno I mT ivlno I ~T M~o ~ 
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Figure 2. ESR spect/~ll ofDA-related co'npouncis (5 mM) lneasured atpH9.5 ol' 12.5 in the absence (A) o"presence of 50%DMSO (B). 
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The fOllowin~* s'eve~~ DA~' were newly h'y~~thesized ~~s recentl.¥* 
p~ibi ished ( 1 7). . !V-[,_-(_3･4-din~cthoxypheny. l)ethyl] -,¥,'-meth ~Inestilfony-
la}~~nine (KDl, [:71, m.w. 33 i..1 l, oi}). N-[2-(3.4-dimc',thoxyphenyl)ethy}]-
N-trilhioromethtmcs'uli'()^~vyialanine (KD'_, [8], m.~v. 385.3(')., mpll5-
1 1 ()_ ' C'). N-(2-phenyiethyl)-N-tnfh~oromethanesulfon)'1glycine (KD3, [9]-
m.w. 3 1 1 .'_8, mp 1 4()- i _~~ I ' C). N-j 2-(-3.4-dimethoxyphenyl)ethyl]-N-
tri{'iuoromethrmesu]i'onylglycine (KD4, [i Ol, m.~~'. 371 .33, mp I I '_-1 13 ' C), 
N-1'-(3,4-dimcth0. xypheny])ethyll-N-tr~.'fluoromethanesulfonylv'aline 
(KD5, Il.11, m.w. 41.3.il, oil), N-[2-(3.4-dh~liethoxypheny])cthyl]-'_-
p,hcnyl-N-trifluorometh',inesulfony~lv. cinc (KD(), jl'_], ~n.¥v. 447.1O, oil) 
tind 2-(3,4-climc.thoxyphenyl)ethy]amine oxal~~te (KD7, [13]. m.~v. 27i .27, 
mp lgl-18~_ 'C (EtOH). An2rl.Ca}cd. for Ci2Hl7NO(~: C, _~~3_ .1.3; H. (~.3'*' 
N, 5.1O. Founci C, _5_3.O2; hl, ().2O; N, 4.9. 3 ) Thc structures oi these 
compou~~ds arc sho¥vn in I'~igtlre l. 
Cd! cultl,t,~?. Human promyei(')cytic le~rkemic HL-()O cells ¥ve~'c cultured 
in RPMI i()4O medium supplemented with I Orl~=~ FBS (1S). 
??
C)toto.ric a(,'tiT,ii_y. HI_-('~O ccl]s (1 x lO /mL) ¥vere incub. ated for 24 hours 
with v2~rious conce~stratio~ss oi' test samples in thc cultured meciit~m, and 
the viab< Ie cel] number ¥v~is determined b~ y trypan hlue dyc exclusion (18). 
The 5O(,/r, cytotoxic concentration (CC50) of e~~ch compound ¥v2~s 
c{etermined b~ y dt)se-rc.sponse curve. 
Ass(ly for radical iiltcnsiiy. Radical intensit.¥' of test samples was 
cietermined at 25"C cxactly I minute arfter mixing sample~ in phosphate-
bu{'ferecl saline (pH7.4) O. I M 'I'ris-HCI (pH().5) or O.lM KOH (pH12._~~) 
with ESR spcctroscopy (JEOL JES REiX, X-banci, 1.0O kHz modu]trtion 
frequency). Instrument settii~gs: centcr fielc{, 336.0 t _~.O mT; microwave 
power, g mW; mociui{rti(,)n amplitt~cie O.1 mT; gain. ~._-1() x lOO: tilnc 
constant, O.1 seconci; scannin~ time, 4 minutc.s. Radic'al intensitv. was 
c{efined as the ratio, of pe~rk hei_(*･hts of these raciicals to that of MnO (13-
16). 
P,(~p(1;~rtion oJ' homo,~'c'nale. M2tle Wistar rats (7 wceks old) (Sankyo 
l..abo. Tokyo) ¥vere dec2~pitnted. The ¥vhole brai~~ ~¥'2is excised ~ind, ai'ter 
remo.val of the cereheliulr}, was homogenizeci by a Teilon-(*~lass 
homo~e~]izer in 4 vi)lumes of ice-colci Ki'ebs Ringer solution (pll7.4) 
saturated with ()5r/o oxygen. 
J'JI)1_C c!et(･,71?ination oj'tota! (Iscorbic ac'ici. 50 ~tL tissue homogenate w{Is 
mixed with 4_~O ~~1_. 5('/!, mctaphosphoric acid cont~lining 20 I,~M 
ciel'e~'oxamine, and centrifuged tit 4'C for lO nlin~~tes 2rt 300O g. 150 ~tL 
of the st~pcrn2itant w~ls mixed ~vith _5O ~~L dithiothreitol (5O mM) a~~d 50 
~tL K21.iP04 (40 mM) (pH S.()). The mixture w~~s re~.lcted for '.-O minutes 
at roo.m temperature in the dtlrk. 2inci addeci 5O ~tL oi' _~~Oc.lc 
met2~pho, sphoric acid. After centrift~g'ation ',rt 3 ,OO() .:~<' for l.() mintrtes, the 
supernsrttint was filterecl through a celluiose nitrate membrane (pore 
size: O.2~- Itm; Miilipo,re. Bedf.orci. MA, U.S.A.). The filtrate was 
immedit~teiv uscd to detc~'mine the total ascorbic acid. Ascorb~ate was 
analyseci by I=1.PLC system with electrochen~ical cletection (ECD) 
accorciing to the method of lriv. ama with somc modificatiol~s (i9). The 
mobi]e phslse co~ ~~sists (). f (.).~._M KI-1.*PO4-]13P04 (pH 3) containing 5() ~,iM 
EDTA. The s'olution wsis fiitered through a cellu]ose nitrate membrane 
(pore si7_e: O.45 f,w; M.iilipo, re) and deg{iss'ed before use. A ilow r~rte of 
l .(:) mLlmin wt~s mtiint;~ineci with a duz~l piston pui~lp (CCPT, Tosoh, 
Tokyo). A 4,() x 1~~O-mm reverse-phalse coiumn (W2tko,sil-H, SC18-lOO; 
Watko P~~re Chem. r~~d. Ltd., Os',tk',1) was used for separation. The 
applieci potential on the amrperometric cletector (ECD-1OO. Eicom, 
ICyoto) was +()_~O I~~V. 
Ca!ci.i!crtion. ~T-Spin density (~+~~:) of DAS [1-131 was c'alculated b.y 
unrcstricteci },-1.'atree-f~~ock/Par'ametric methoci 3 (UHF/PM_3 method) 
(2O). The geometries of the c2rticu~ radical species ~verc optimizecl with 
respect to 2~li geon~etric211 p'arameters using Broyden-Fletcher-Goldfarb-
shtinno algorithm inc{)rporated in the p~'ogram. For these caicult~tions, 
Ttlhle l. C:yfoio"~ic c cti~'i!y ai~d radiccil in!e;~sff)' ()./' DA-,'d(~t~d compou;Ids 
f 1-1 3 j. 
Compounci
(No.) 
Cytotoxic Raciical Rat hrain homoge~~~itc 
2ictivity int nsity (CC50 mM) ~) i ) Decre~ls'e of Dccrease of ~ (pl.1 11~_._5  2~scorh< 2rte a~sco~~b. 2it  
concen~_r2itiOn ~'2idic',~l inte~~sity ?? ??
((/,) ((//(,) 
Control 
DA Ilj 
NE [2] 
DOPAC [3] 
DOMA [4] 
MT [_~~] 
NMN [6j 
KDI [7] 
KD2 [8] 
KD_,' {9] 
KD4 [iO] 
KD5 [ll] 
KD6 [12] 
KD7 [13] 
O. I l 
O.23 
O.79
> :1 (  
()*4 
7.() 
> lO 
3.6 
1,*.4 
(~.2 
().(~ 
0 43
2.0 
2. 1 3 
l.2S 
~3.,~7 
O .26 
<0.Ol 
< O O 1 
< O.O 1 
<O.O1 
< O.O i 
< O.O I 
< O.O 1 
< O.O l 
< O.O i 
24 6 
S6,4 
()()*4 
()1 .9 
47.2 
49*O 
33*O 
28.7 
26.3 
3_ 2, 1 
?_7.8 
2･,~.4 
25._~* 
,~9.7 
43*4 
()O.,~ 
N.D e) 
N.D, 
N.D. 
N.D. 
N.D. 
37, 1 
37.() 
3- 4*O 
28.O 
i5.() 
37.() 
3~3.3 
'a) HL-6O cells ( i x lO(~/mL) we~'e incuh. ated ror 20 hours with v~~ri(:)us 
concentrations of each compound, 2~nc{ viabie celi number was 
deten~~ineci by tl~;pan blue dye exclusio. n. 
b) The i'2~dia] intensity of the hihgest petrk was cieten~~inecl b.y ES"R 
spectroscopy in _5O(/;, DMSO, pH 1･_.5 (ci~~ta f'~'om Figurc 2B). 
c) Determined by the ciii'ference b.etween () and ()O-minutes incuh.~.~tion 
(dat2i i'~-om Figt~rc 3). 
cl) Determined by the dif{'erence b~ et¥veen lO- and ()O-minutes incuh~ ~ltion 
(data f~'om Figure 4). 
e) N.D.: not dctermined. 
thc FACOM M3_30 computei' in the Josai Universit}' hlformation 
Sciences Center was i~seci. ~c-Spin ciensity ((*)") was dei~ineci as the ct-spi~~ 
densit}' I~linus the f3-spin density. 
Results 
Cy'tot xic y. Milli nolar concentrations of ctrtecholamines 
(DA [1], NE [2]) and DOPAC [3] ¥~'ere cytotoxic to HL-6(') 
cells. Among these compounds, the cytotoxic activity of DA 
[1] was the gre',rtest (CC_~-() = 0.11 mM), i:ollowed by NE [2] 
(CC5C = O'23 mM) and DOPAC [3] (CC5O = 0.79 mM) 
(Table I). 
However, the cytotoxic activity of their metabolites 
(DOMA [4], MT [5], NMN [6] (CC_5O = >lO, ().4, 7.6 mM, 
respectively) and six synthetic derivatives (KDl_-1CD5 [7-11] 
ancl KD7 [13]), ¥vhich have two methoxy groups (OCH3_) 
replacing two hydroxyl groups (OH) or none of these 
functional groups in catechol backbone (CC_~-0 = > 10, 3.6, 
2.4, 6.2, 9.6, 2.0 mM, respectively) were much less (Table I). 
Radical genel~rtion. ESR spectroscopy delTionstrated th'.rt DA 
[1], NE [2], DOPAC [3] a d DOMA [4] produced radicals at 
l 071 
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Figure 3 . Effect oJ'DA-related co,npounds On the concentrations of asco,hic acid endogenously present in 11~It brain holnoge/7ate. 
Rat bruin homogenate was ,nixed with O. J mM each test compouncl, ancl incubated at _?7'C fol' O ol' 60 minutes. The remaining asco,hic acid concentration 
14'as dete,7nined by HPLC. 
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Figure 4. Effect of DA-related compounds on the '~lrdical inten.~ity of ascoihic acid enclogenously present in rat brain homogenate. 
Rat brain homogenate was incubatecl fo" the illdicatecl ti,nes at 37'C without (O) ol' with O. J JnM DA flJ o" synthetic DAS KD1-KD7 /7-13J, an4 the 'udical 
in tens!ty ,4'as clete'7n in ed by ESR ,spect,vscopy. 
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Figurc 5. ;7-SJ'in densil.y of DA-!~~laled co'npoullcis 11-6j by UHF/P,~t3 ,nethocl. 
pH9._5, and their r'adical intensity was significantly increased 
when the pH was elevated up to 1<'_.5 (Figure 2A). In 50alo 
DMSO solution, these compounds produced only minor 
radical intensity at pH9.5, but their r,adical intensity became 
much large<r at pH12.5 (Figure 2B). It should be noted that 
DOMA [4], which did not show any significant cytotoxic 
activity (T'able I), produced only trace amounts of radical 
intensity 'at pH 12.5 (Figure 2B). 
On the other hand, MT [5], NMN [6] (Figures 2A and 2B) 
and seven synthetic compotmds KD1-7 .[7-13] (Table I) 
producecl no detectable radical at pH9.5-1~_.5. 
EJfL･ct on ascol'bic acicl metabolism. Rat brain homogenate 
contained 145 L,=rg ascorbic acid/g wet tissue. The addition of 
DA [1], NE [2], DOPAC [3] or DOMA [4] significantly 
enhanced the clecay of ascorbic acid (Figure 3). MT [5] and 
NMN [6] showed only marginal effects. Synthetic compounds 
KD1-7 [7=13] were essentially inactive (Figure _3). 
When the rat brain homogenate was incubated in Krebs 
Ringer solution (pH7.4), the r',tdical intensit.v of ascorbic, acid 
endogenously present in the homogenate was significantly 
enhanced within 10 minutes and gradu'ally declined thereafter 
(Figure 4). The addition of DA [1] to the homogenate 
significantly 'accelerated the decay of the 'ascorbate radical 
intensity, possibly due to the loss of intact ascorbate molecule. 
On the other hand, the addition of any synthetic compounds 
(KD l.-7) [7-13], clld not significantly change the turnover 
pattern of 'ascorbate raciical intensity (Figure 4). 
~fJ~ct on ;7-spin. cle,7sity. Figure 5 shows th'at oxygen or carbon 
atom in the active compounds (DA [1], NE [2], DOPAC [3] 
and DOMA [4]) or inactive compounds (MT [5] and NMN 
[6]) showecl similar v'alue of Te-spin density, calculated in gas 
phase. This indicates that their calculated values of Te-spin 
density do not correiate with the radical intensity or cytotoxic 
activity of each dopamine. 
Interac iol7, bet,4*c'en DA ai7cl ascolhatc'. Figure 6A shows th',it 
both DA and ascorbic acid dose-dependently reduced the 
viable cell umber of HL-60 cells. The CC50 of these 
compounds was 0.11 mM (for DA [l]) and O.5 mM (for 
ascorbic acid), respectively. However, combination of these 
two compounds neutralized their cytotoxic activity with each 
other, suggesting the interaction between DA and ascorbic acid 
(Figure 6). We also found a similar interaction between DA [1] 
and sodium 5,6-benzylidene-1-ascorbate (SBA) (Fi_~ure 6B), 
which showed potent umor degeneration activity against 
human inoperable tumors and rat chemically-induced 
hepatocellular carcinoma (21 ). 
D scussion 
The pre ent study demonstrated that a) compounds which 
have two ortho phenolic OH groups in the catechol backbone 
(DA [1], NE [2] and DOPAC [3]) were cytotoxic, and b) 
those which have ne (MT [5], NMN [6]) or no OH group in 
the cat chol b ckbone (KD1-KD5 [7-1l], KD7 [13]) 
displayed much lower cytotoxic activity (Table I). This 
suggests the importance of catechol backbone for cytotoxicity 
induc ion. We found that catecholamines, which produced 
the rad cals, were cytotoxic, whereas their derivatives, which 
did not produce radicals, were not cytotoxic except for KD6 
[12] (Table I). This finding suggests that radical pi'oduction 
might initiate the si!_-'nalling pathway leading to cell death. 
However, ICD6 [12], which has no OH group but two 
OCH3 group in the catechol backbone, was highly cytotoxic 
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nerve diseases such as Parkinsonism. Further study of the 
changes in the redox potential after treatment with DA [1] 
and ascorbic acid is underway in our laboratory. 
References 
10 
O 0.1 1 10 SBA (mM) 
Figure 6. Effect of' sodiu.m asco'ha.te o" SBA on DA flj-ilrduced 
rytoto.~ricity in HL-60 cells. 
HL-60 cells were incubatecl fb,' 24 hoLirs with t/7.e inc!icatecl concentrations 
ofsoclium asco'hcrte (A) o" socliu'n 5,6-ben2ylidene-1-ascoihate (SBA) (B) 
in the presen.ce of O (O: control), O.03 (1). 0.3 (A) o" 3 (V) lnM DA flJ 
and the viable cell nu'nbe" was thell. dete'7nined by t,ypan bhie ciye 
c'xcl usion. 
(CC50 = 0.43 mM), even though this compound did not 
produce radicals (Table I). This might be due to the 
phenylglycine site, which is present only in the KD6 [12] 
molecule. It is predictable that radical spin density on benzyl 
carbon of a center of phenylglycine site might have an 
important role on cytotoxic activity. This indicates that 
catecholamines and KD6 [12] induce cytotoxicity by different 
mechanisms. Thus, the introduction of two ortho phenolic OH 
group to KD6 [12] might further enhance its cytotoxic activity. 
The present study also demonstrated that DA [1] enhanced 
the decay of ascorbic acid in rat brain homogenate (Figure 3). 
The possibility should be investigated that DA [1] might 
enhance the degradation of ascorbic acid or sirnply make a 
complex with ascorbic acid (9-11), which elutes at different 
retention times on HPLC separation. We found that DA [1] 
and ascorbic acid interacted with each other, thus reducing 
their individual cytotoxic activity. This suggests that ascorbic 
acid mrg*ht affect the DA metabolism, and dDA-mediated 
1 Y'amafuji K, Murakami H and Shinozuka M: Antitumor activity of 
dopa, dopamine, noradrenalin or adrenalin and their reaction with 
nucleic acids. Z Krebsfosch 73; 195-203, 1970. 
2 Dasgupta PS and Lahiri T: Dopamine inhibits sarcoma-180 tumor 
growth in vivo. Indian J Cancer Chemother 7: 27-30, 1985. 
3 Chelmicka-Szorc E and Arnason B: Effect of 6-hydroxydopamine on 
tumor growth. Cancer Res _?6.･ 2382-2384, 1976. 
4 Boulos BM, Dajuvone C and Azarnoff DL: A new method for 
increasing chemotherapeutic drug concentration in the tumor tissue. 
Panminerva Med J8; 95-98, 1976. 
5 (a) Prasad KN. Gilmer KN, Sahu SK and Becker G: Effect of 
neurotransmitters, guanosine triphosphate, and divalent ions on the 
regulation of adenylate cyc]ase activity in malignant and adenosine 
cyclic 3':5'-monophosphate-induced "differentiated" neuroblastorna 
cells. Cancer Res 35.･ 77-81, 1975. (b) Kumar S, Becker G and Prasad 
KN: Cyclic adenosine 3':5'-monophosphate phosphodiesterase 
activity in malignant and cyclic adenosine 3':5'-monophosphate-
induced "differentiated" neuroblastoma cells. Cancer Res 35, 82-87, 
1975. 
6 Wick MM: Levodopa and dopamine analogs: Dihydroxy and 
trihydroxybenzylamines as novel quinol antitumor agents in 
experimental leukemia in vivo. Cancer Treat Rep 65.･ 861-867, 1981. 
7 Drisco]1 JS. Melnick NR, Quinn FR, Lomax N, Davignon JP, Ing R, 
Abbott BJ, Congleton G and Dudeck L: Psychotropic drugs as 
potential antitumor agents: A selective screening study. Cancer Treat 
Rep 62, 45-74, 1978. 
8 Driscoll J: Catecholamine analogs as potential antitumor agents. J 
Pharm Sci 68.･ 1519-1521, 1979. 
9 Reynolds CP and Perez-Polo JR: Ascorbic acid enhances the 
cytotoxic effect of 6-hydroxydopamine for human neuroblastoma ce]l 
lines. Neurosci Lett 26: 151-155, 1981. 
10 Tiffany-Castiglioni E. Saneto RP, Proctor PH and Perez-Polo JR: 
Participation of active oxy**en species in 6-hydroxydopamine toxicity 
to a human neuroblastoma cell line. Biochem Pharmacol 31: 181-188, 
1982. 
11 Uretsky NJ <and lversen LL: Effects of 6-hydroxydopamine on 
noradrenaline-containing neurons in the rat brain. Nature 221; 557-
559, 1969. 
12 Purpura P, Westman L, Will P, Eidelman A, Kagan VE, Osipov AN 
',md Schor NF: Adjunctive treatment of murine neuroblastoma with 6-
hydroxydopamine and tempol. Cancer Res 56.･ 2336-2342, 1996. 
13 Sakagami H, Satoh K. Ohata H, Takahashi H, Yoshida H, Iida M, 
Kuribayashi N. Sakagami T, Momose K and Takeda M: Re]ationship 
between ascorbyl radical intensity and apoptosis-inducing activity. 
Anticancer Res J6.･ 2635-2644, 1996. 
14 Sakagami H. Satoh IC, Hatano T, Yoshida T and Okuda T: Possible 
role of radical intensity and oxidation potential for gallic acid-induced 
apoptosis. Anticancer Res 17.･ 377-380, 1997. 
15 S<atoh K, Sakagami H and Motohashi N: Radicai moduiation activity 
of benz [a]phenothiazine. Anticancer Res 17, 2539-2544, 19. 97. 
16 Satoh K, Sakagami H, Kurihara T and Motohashi N: Radical intensity 
and differentiation-inducing activity of benzo[a]phenothiazines and 
phenothiazin s. Anticancer Res 17, 2465-2470, 1997. 
17Kawase M, Motohashi N, Niwa M and Nozaki M: Use of the 
triflamide group for Friedel-Crafts acylation of N-(B-phenethy]) 
amino acids to 3-benzazepine derivatives. Heterocycle~ 45: 1 121-1 129, 
1997. 
18 Sakagami H, Satoh IC, Fukuchi K, Gomi K and Takeda M: Effect of 
an iron-chelator on ascorbate-induced cytotoxicity. Free Radic Biol 
Med 23.･ 260-270, 1997. 
19 Iriyama K. Yoshiura M. I¥vamoto T and Ozaki Y: Simultaneous 
determination of uric and ascorbic acids in human serum by reversed-
phase high-performance liquid chromatography with electrochemical 
detection. Anal Biochem 14J: 238-243, 1984. 
20 Stewart JJP: MOPAC 93. JCPE#P081. 
21 Sakagami H, Asano K, Fukuchi K, Gomi IC. Ota H, Kazama K, 
Tanuma S and Kochi K: Induction of tumor degeneration by sodium 
benzylideneascorbate. Anticancer Res 11.･ 1533-1538, 1-991. 
Received Novembe/･ 18, 1997 
Accepted December 29, 1997 
1 074 
